Comment
doi: 10.1056/NEJMc2108076.
Epub 2021 Aug 18.
Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers
Affiliations
- PMID: 34407332
- PMCID: PMC8385562
- DOI: 10.1056/NEJMc2108076
Item in Clipboard
Comment
Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers
N Engl J Med.
.
No abstract available
Comment on
-
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.N Engl J Med. 2021 Jun 10;384(23):2212-2218. doi: 10.1056/NEJMoa2105000. Epub 2021 Apr 21. N Engl J Med. 2021. PMID: 33882219 Free PMC article.
Similar articles
-
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2. Lancet Respir Med. 2021. PMID: 34224675 Free PMC article.
-
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2. Lancet Haematol. 2021. PMID: 34224668 Free PMC article.
-
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.N Engl J Med. 2021 May 6;384(18):1775-1777. doi: 10.1056/NEJMc2101951. Epub 2021 Mar 23. N Engl J Med. 2021. PMID: 33755373 Free PMC article. No abstract available.
-
Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.J Korean Med Sci. 2021 May 3;36(17):e115. doi: 10.3346/jkms.2021.36.e115. J Korean Med Sci. 2021. PMID: 33942579 Free PMC article.
-
Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization.J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e425-e427. doi: 10.1111/jdv.17250. Epub 2021 Apr 19. J Eur Acad Dermatol Venereol. 2021. PMID: 33783873 Free PMC article. No abstract available.
Cited by
-
Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus.ACS Pharmacol Transl Sci. 2023 Jun 5;6(7):925-942. doi: 10.1021/acsptsci.3c00042. eCollection 2023 Jul 14. ACS Pharmacol Transl Sci. 2023. PMID: 37470012 Free PMC article. Review.
-
Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.PLoS One. 2023 Apr 13;18(4):e0281395. doi: 10.1371/journal.pone.0281395. eCollection 2023. PLoS One. 2023. PMID: 37053270 Free PMC article.
-
Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice.Vaccines (Basel). 2022 Dec 23;11(1):30. doi: 10.3390/vaccines11010030. Vaccines (Basel). 2022. PMID: 36679875 Free PMC article.
-
Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections.Front Immunol. 2022 Nov 18;13:1035111. doi: 10.3389/fimmu.2022.1035111. eCollection 2022. Front Immunol. 2022. PMID: 36466827 Free PMC article.
-
Short-Term Adverse Effects Immediately after the Start of COVID-19 Booster Vaccination in Vietnam.Vaccines (Basel). 2022 Aug 16;10(8):1325. doi: 10.3390/vaccines10081325. Vaccines (Basel). 2022. PMID: 36016213 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
